Hi, my name is Martijn Bijker and I am the
founder of the global MSL training company
called “from SCIENCE to PHARMA” and I
am your host today and will be recording this from
my studio, my balcony, in 
sunny winter in Sydney.
Welcome to the first ever Medical Science Liaison youtube Channel episode
where we will be answering all your questions about Medical Science Liaison and
Medical Affairs questions, any new
developments in the pharmaceutical industry
and anything more.
Before we start, make sure you subscribe here at the bottom
to this channel so you will be kept uptodate on any new developments
So let’s get started with our first ever Question "WHAT IS AN MSL" or "WHAT DOES AN MSL DO"?
It is probably the most common asked questions
and probably the simplest question.
But probably also the hardest to answer.
The MSL role is quite, and it is a role within in the pharmaceutical industry and biotech company.
And the name already says what it does.
You liaise between the company and the external stakeholders
on anything that is medical and scientific related.
The objective of most MSLs is to support a best in class launch of a pipeline drug and
make sure that are there little to no barriers
for uptake of this drug once it comes to the market
after the regulators have approved the drug.
This is easier said than done.
As every drug and every disease and every territory or even every country comes with its own challenges.
Based on your overall brand and medical plan you will have your own in-field medical plan as a Medical Science Liaison
where you will work and reach out to many of the different stakeholders that we often call KOLs
or also called Key Opinion Leaders.
These key opinion leaders could be anyone, like: clinicians, head of department,
head of pharmacy, nurses, professors, payers, insurance, you name it, it can be anyone
Anyone that is important for your drug in
that part of the product life cycle.
Besides being involved in a lot of medical
projects and educational projects you will
also have a lot of peer-to-peer discussions with your
KOLs in which you often use clinical papers
or conference abstracts.
In these meetings you will try to create familiarity
for your clinical data and develop advocacy
for your drug by highlighting how your drug will
addresses the unmet medical needs of the patient.
During these conversations you will also try to uncover how your drug fits in to the current treatment algorithm
and how it can potentially change disease management and patient management in the future.
Are there any risk, or challenges with the
drug that you need to mitigate quickly
in order to make sure that this drug will be a success once the drug is approved
so a success for the 
patients, doctors and also the company.
And all this information you obtained in your clinical discussion or in your presentations with these KOLs
you will feedback to the internal stakeholders and that will further drive the strategy internally
So, this is the MSL role in short.
It is actually quite a lot more complex than this, but let's get back in to that in later episodes.
So, if you are interested to know more about how to transition into an MSL role without industry experience,
just scroll down and join our FREE - there is actually a link - join our free webinar and sign up to that
if you just remember it it is   www.fromSCIENCEtoPHARMA.com/resources
Don’t forget to subscribe to the channel,
give it a thumbs up or a 5 star rating
and if youd like to translate this video in any of your own favorite languages,
please do so and it would make my day.
Thank you very much for  attending our first MSL youtube channel episode
And look forward to seeing you in the future. 
See you.
